Business
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
LONDON and PHILADELPHIA , March 10, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the Company will present at the Leerink Global Healthcare Conference on Wednesday, March 12, 2025, at 10:00 a.m. ET in Miami. A live webcast of the presentation will be available in the investors section of the Company’s website at https://av
About this update from Avacta Group Plc
[{"type":"image","alt":"AVACTA GROUP PLC","displaySize":"","headline":null,"caption":"AVACTA GROUP PLC","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":109,"url":"https://media.zenfs.com/en/globenewswire.com/2179b51c1f91cddf1addee3cc0dee04b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/BuJbdPFE1KPW3OqbkUSHWA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2179b51c1f91cddf1addee3cc0dee04b","width":300,"height":109}},"lazy":false},{"type":"text","content":"LONDON and PHILADELPHIA , March 10, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announced that the Company will present at the Leerink Global Healthcare Conference on Wednesday, March 12, 2025, at 10:00 a.m. ET in Miami.","length":383,"tagName":"p"},{"type":"text","content":"A live webcast of the presentation will be available in the investors section of the Company’s website at https://avacta.com/investors. The webcast will be archived for at least 30 days following the presentation.","length":213,"tagName":"p"},{"type":"text","content":"For further information from Avacta, please contact:","length":52,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:304.27px;vertical-align:top;","val":[{"type":"text","content":"Avacta Group plcMichael Vinegrad, Group CommunicationsDirector","length":64,"tagName":"p","attribs":{}}]},{"style":"width:247.47px;vertical-align:top;","val":[{"type":"text","content":"www.avacta.com","length":14,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:304.27px;vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]},{"style":"width:247.47px;vertical-align:top;","val":[{"type":"text","content":" ","length":6,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:304.27px;vertical-align:top;","val":[{"type":"text","content":"Peel Hunt (Nomad and Broker)James Steel / Chris Golden / Patrick Birkholm","length":74,"tagName":"p","attribs":{}}]},{"style":"width:247.47px;vertical-align:top;","val":[{"type":"text","content":"www.peelhunt.com","length":17,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:304.27px;vertical-align:top;","val":[{"type":"te...